Vivanza Biosciences Ltd
₹0.00▲ +0.00 (+0.00%)
530057·NSE·Healthcare
Market Cap
7.50 Cr
PE Ratio
18.70
Volume
—
Day High - Low
—
52W High-Low
2.72 - 1.52
₹0.00▲ +0.00 (+0.00%)
Market Cap7.50 Cr
PE Ratio18.70
Volume—
Day High - Low—
52W High-Low2.72 - 1.52
Vivanza Biosciences Ltd (530057): company summary
Vivanza Biosciences Ltd (530057) is a micro-cap Healthcare company valued at ₹8 crore operating in Pharmaceuticals on the NSE and BSE.
Vivanza Biosciences Ltd (530057) is a micro-cap Healthcare company valued at ₹8 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 86.1% a year over three years. Return on equity is 9.4%.
- Valuation multiples
- The stock trades at 18.7 times earnings, a discount to the Healthcare median of 32.5, 1.72 times book value.
- Things to watch
- Debt is 2.00 times equity.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
0.2/10
Poor
Fair Value
Sign in to see
ROE
9.38%
Average
P/E
18.70x
Fair
Debt / Equity
2.00
High
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
52W₹1.52
₹2.72
DocStoX take
Supported by growth (9.0), but held back by risk (0.0). Growth looks strong at 9.0, but that is offset by risk at 0.0 and quality at 0.4. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence0.2
/10
Poor
Quality
Weak
ROE 9.4%
Valuation
Rich
P/E 18.7×
Growth
Strong
Revenue +63.3% 5Y CAGR
Risk
High risk
D/E 2.00
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹8 Cr
52W High / Low
₹3 / ₹2
Dividend Yield
0.00%
Promoter Holding
20.02%
EPS (TTM)
₹0.10
Book Value
₹1.09
Key highlights
- Revenue compounding 63% a year
- High leverage — debt is 2.0× equity
- Loss-making in some of the last 5 years
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Vivanza Biosciences Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Vivanza Biosciences Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED
Compare Vivanza Biosciences Ltd with peers
Related tools & concepts
Value Vivanza Biosciences Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing